Medical Care
Global Faecal Microbiota Transplant(FMT) Therapy Market Research Report 2025
- May 05, 25
- ID: 226576
- Pages: 73
- Figures: 80
- Views: 34
The global market for Faecal Microbiota Transplant(FMT) Therapy was valued at US$ 1957 million in the year 2024 and is projected to reach a revised size of US$ 2722 million by 2031, growing at a CAGR of 4.9% during the forecast period.
North American market for Faecal Microbiota Transplant(FMT) Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Faecal Microbiota Transplant(FMT) Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Faecal Microbiota Transplant(FMT) Therapy in Clostridioides Difficile Infection(CDI) is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Faecal Microbiota Transplant(FMT) Therapy include Enterome Bioscience, Rebiotix, Ritter Pharmaceuticals, Finch Therapeutics, Crestovo, Maat Pharma, Seres Therapeutics, Second Genome, OpenBiome, MicroBiome Therapeutics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Faecal Microbiota Transplant(FMT) Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Faecal Microbiota Transplant(FMT) Therapy.
The Faecal Microbiota Transplant(FMT) Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Faecal Microbiota Transplant(FMT) Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Faecal Microbiota Transplant(FMT) Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Enterome Bioscience
Rebiotix
Ritter Pharmaceuticals
Finch Therapeutics
Crestovo
Maat Pharma
Seres Therapeutics
Second Genome
OpenBiome
MicroBiome Therapeutics
Segment by Type
Oral
Enema
Segment by Application
Clostridioides Difficile Infection(CDI)
Digestive System Disease
Nervous System Disease
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Faecal Microbiota Transplant(FMT) Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
North American market for Faecal Microbiota Transplant(FMT) Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Faecal Microbiota Transplant(FMT) Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Faecal Microbiota Transplant(FMT) Therapy in Clostridioides Difficile Infection(CDI) is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Faecal Microbiota Transplant(FMT) Therapy include Enterome Bioscience, Rebiotix, Ritter Pharmaceuticals, Finch Therapeutics, Crestovo, Maat Pharma, Seres Therapeutics, Second Genome, OpenBiome, MicroBiome Therapeutics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Faecal Microbiota Transplant(FMT) Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Faecal Microbiota Transplant(FMT) Therapy.
The Faecal Microbiota Transplant(FMT) Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Faecal Microbiota Transplant(FMT) Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Faecal Microbiota Transplant(FMT) Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Enterome Bioscience
Rebiotix
Ritter Pharmaceuticals
Finch Therapeutics
Crestovo
Maat Pharma
Seres Therapeutics
Second Genome
OpenBiome
MicroBiome Therapeutics
Segment by Type
Oral
Enema
Segment by Application
Clostridioides Difficile Infection(CDI)
Digestive System Disease
Nervous System Disease
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Faecal Microbiota Transplant(FMT) Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Faecal Microbiota Transplant(FMT) Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Oral
1.2.3 Enema
1.3 Market by Application
1.3.1 Global Faecal Microbiota Transplant(FMT) Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clostridioides Difficile Infection(CDI)
1.3.3 Digestive System Disease
1.3.4 Nervous System Disease
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Faecal Microbiota Transplant(FMT) Therapy Market Perspective (2020-2031)
2.2 Global Faecal Microbiota Transplant(FMT) Therapy Growth Trends by Region
2.2.1 Global Faecal Microbiota Transplant(FMT) Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Faecal Microbiota Transplant(FMT) Therapy Historic Market Size by Region (2020-2025)
2.2.3 Faecal Microbiota Transplant(FMT) Therapy Forecasted Market Size by Region (2026-2031)
2.3 Faecal Microbiota Transplant(FMT) Therapy Market Dynamics
2.3.1 Faecal Microbiota Transplant(FMT) Therapy Industry Trends
2.3.2 Faecal Microbiota Transplant(FMT) Therapy Market Drivers
2.3.3 Faecal Microbiota Transplant(FMT) Therapy Market Challenges
2.3.4 Faecal Microbiota Transplant(FMT) Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Faecal Microbiota Transplant(FMT) Therapy Players by Revenue
3.1.1 Global Top Faecal Microbiota Transplant(FMT) Therapy Players by Revenue (2020-2025)
3.1.2 Global Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Faecal Microbiota Transplant(FMT) Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Faecal Microbiota Transplant(FMT) Therapy Revenue
3.4 Global Faecal Microbiota Transplant(FMT) Therapy Market Concentration Ratio
3.4.1 Global Faecal Microbiota Transplant(FMT) Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Faecal Microbiota Transplant(FMT) Therapy Revenue in 2024
3.5 Global Key Players of Faecal Microbiota Transplant(FMT) Therapy Head office and Area Served
3.6 Global Key Players of Faecal Microbiota Transplant(FMT) Therapy, Product and Application
3.7 Global Key Players of Faecal Microbiota Transplant(FMT) Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Faecal Microbiota Transplant(FMT) Therapy Breakdown Data by Type
4.1 Global Faecal Microbiota Transplant(FMT) Therapy Historic Market Size by Type (2020-2025)
4.2 Global Faecal Microbiota Transplant(FMT) Therapy Forecasted Market Size by Type (2026-2031)
5 Faecal Microbiota Transplant(FMT) Therapy Breakdown Data by Application
5.1 Global Faecal Microbiota Transplant(FMT) Therapy Historic Market Size by Application (2020-2025)
5.2 Global Faecal Microbiota Transplant(FMT) Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Faecal Microbiota Transplant(FMT) Therapy Market Size (2020-2031)
6.2 North America Faecal Microbiota Transplant(FMT) Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2020-2025)
6.4 North America Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Faecal Microbiota Transplant(FMT) Therapy Market Size (2020-2031)
7.2 Europe Faecal Microbiota Transplant(FMT) Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2020-2025)
7.4 Europe Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Market Size (2020-2031)
8.2 Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Faecal Microbiota Transplant(FMT) Therapy Market Size (2020-2031)
9.2 Latin America Faecal Microbiota Transplant(FMT) Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2020-2025)
9.4 Latin America Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Market Size (2020-2031)
10.2 Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Enterome Bioscience
11.1.1 Enterome Bioscience Company Details
11.1.2 Enterome Bioscience Business Overview
11.1.3 Enterome Bioscience Faecal Microbiota Transplant(FMT) Therapy Introduction
11.1.4 Enterome Bioscience Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025)
11.1.5 Enterome Bioscience Recent Development
11.2 Rebiotix
11.2.1 Rebiotix Company Details
11.2.2 Rebiotix Business Overview
11.2.3 Rebiotix Faecal Microbiota Transplant(FMT) Therapy Introduction
11.2.4 Rebiotix Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025)
11.2.5 Rebiotix Recent Development
11.3 Ritter Pharmaceuticals
11.3.1 Ritter Pharmaceuticals Company Details
11.3.2 Ritter Pharmaceuticals Business Overview
11.3.3 Ritter Pharmaceuticals Faecal Microbiota Transplant(FMT) Therapy Introduction
11.3.4 Ritter Pharmaceuticals Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025)
11.3.5 Ritter Pharmaceuticals Recent Development
11.4 Finch Therapeutics
11.4.1 Finch Therapeutics Company Details
11.4.2 Finch Therapeutics Business Overview
11.4.3 Finch Therapeutics Faecal Microbiota Transplant(FMT) Therapy Introduction
11.4.4 Finch Therapeutics Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025)
11.4.5 Finch Therapeutics Recent Development
11.5 Crestovo
11.5.1 Crestovo Company Details
11.5.2 Crestovo Business Overview
11.5.3 Crestovo Faecal Microbiota Transplant(FMT) Therapy Introduction
11.5.4 Crestovo Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025)
11.5.5 Crestovo Recent Development
11.6 Maat Pharma
11.6.1 Maat Pharma Company Details
11.6.2 Maat Pharma Business Overview
11.6.3 Maat Pharma Faecal Microbiota Transplant(FMT) Therapy Introduction
11.6.4 Maat Pharma Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025)
11.6.5 Maat Pharma Recent Development
11.7 Seres Therapeutics
11.7.1 Seres Therapeutics Company Details
11.7.2 Seres Therapeutics Business Overview
11.7.3 Seres Therapeutics Faecal Microbiota Transplant(FMT) Therapy Introduction
11.7.4 Seres Therapeutics Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025)
11.7.5 Seres Therapeutics Recent Development
11.8 Second Genome
11.8.1 Second Genome Company Details
11.8.2 Second Genome Business Overview
11.8.3 Second Genome Faecal Microbiota Transplant(FMT) Therapy Introduction
11.8.4 Second Genome Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025)
11.8.5 Second Genome Recent Development
11.9 OpenBiome
11.9.1 OpenBiome Company Details
11.9.2 OpenBiome Business Overview
11.9.3 OpenBiome Faecal Microbiota Transplant(FMT) Therapy Introduction
11.9.4 OpenBiome Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025)
11.9.5 OpenBiome Recent Development
11.10 MicroBiome Therapeutics
11.10.1 MicroBiome Therapeutics Company Details
11.10.2 MicroBiome Therapeutics Business Overview
11.10.3 MicroBiome Therapeutics Faecal Microbiota Transplant(FMT) Therapy Introduction
11.10.4 MicroBiome Therapeutics Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025)
11.10.5 MicroBiome Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Faecal Microbiota Transplant(FMT) Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Oral
1.2.3 Enema
1.3 Market by Application
1.3.1 Global Faecal Microbiota Transplant(FMT) Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clostridioides Difficile Infection(CDI)
1.3.3 Digestive System Disease
1.3.4 Nervous System Disease
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Faecal Microbiota Transplant(FMT) Therapy Market Perspective (2020-2031)
2.2 Global Faecal Microbiota Transplant(FMT) Therapy Growth Trends by Region
2.2.1 Global Faecal Microbiota Transplant(FMT) Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Faecal Microbiota Transplant(FMT) Therapy Historic Market Size by Region (2020-2025)
2.2.3 Faecal Microbiota Transplant(FMT) Therapy Forecasted Market Size by Region (2026-2031)
2.3 Faecal Microbiota Transplant(FMT) Therapy Market Dynamics
2.3.1 Faecal Microbiota Transplant(FMT) Therapy Industry Trends
2.3.2 Faecal Microbiota Transplant(FMT) Therapy Market Drivers
2.3.3 Faecal Microbiota Transplant(FMT) Therapy Market Challenges
2.3.4 Faecal Microbiota Transplant(FMT) Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Faecal Microbiota Transplant(FMT) Therapy Players by Revenue
3.1.1 Global Top Faecal Microbiota Transplant(FMT) Therapy Players by Revenue (2020-2025)
3.1.2 Global Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Faecal Microbiota Transplant(FMT) Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Faecal Microbiota Transplant(FMT) Therapy Revenue
3.4 Global Faecal Microbiota Transplant(FMT) Therapy Market Concentration Ratio
3.4.1 Global Faecal Microbiota Transplant(FMT) Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Faecal Microbiota Transplant(FMT) Therapy Revenue in 2024
3.5 Global Key Players of Faecal Microbiota Transplant(FMT) Therapy Head office and Area Served
3.6 Global Key Players of Faecal Microbiota Transplant(FMT) Therapy, Product and Application
3.7 Global Key Players of Faecal Microbiota Transplant(FMT) Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Faecal Microbiota Transplant(FMT) Therapy Breakdown Data by Type
4.1 Global Faecal Microbiota Transplant(FMT) Therapy Historic Market Size by Type (2020-2025)
4.2 Global Faecal Microbiota Transplant(FMT) Therapy Forecasted Market Size by Type (2026-2031)
5 Faecal Microbiota Transplant(FMT) Therapy Breakdown Data by Application
5.1 Global Faecal Microbiota Transplant(FMT) Therapy Historic Market Size by Application (2020-2025)
5.2 Global Faecal Microbiota Transplant(FMT) Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Faecal Microbiota Transplant(FMT) Therapy Market Size (2020-2031)
6.2 North America Faecal Microbiota Transplant(FMT) Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2020-2025)
6.4 North America Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Faecal Microbiota Transplant(FMT) Therapy Market Size (2020-2031)
7.2 Europe Faecal Microbiota Transplant(FMT) Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2020-2025)
7.4 Europe Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Market Size (2020-2031)
8.2 Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Faecal Microbiota Transplant(FMT) Therapy Market Size (2020-2031)
9.2 Latin America Faecal Microbiota Transplant(FMT) Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2020-2025)
9.4 Latin America Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Market Size (2020-2031)
10.2 Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Enterome Bioscience
11.1.1 Enterome Bioscience Company Details
11.1.2 Enterome Bioscience Business Overview
11.1.3 Enterome Bioscience Faecal Microbiota Transplant(FMT) Therapy Introduction
11.1.4 Enterome Bioscience Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025)
11.1.5 Enterome Bioscience Recent Development
11.2 Rebiotix
11.2.1 Rebiotix Company Details
11.2.2 Rebiotix Business Overview
11.2.3 Rebiotix Faecal Microbiota Transplant(FMT) Therapy Introduction
11.2.4 Rebiotix Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025)
11.2.5 Rebiotix Recent Development
11.3 Ritter Pharmaceuticals
11.3.1 Ritter Pharmaceuticals Company Details
11.3.2 Ritter Pharmaceuticals Business Overview
11.3.3 Ritter Pharmaceuticals Faecal Microbiota Transplant(FMT) Therapy Introduction
11.3.4 Ritter Pharmaceuticals Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025)
11.3.5 Ritter Pharmaceuticals Recent Development
11.4 Finch Therapeutics
11.4.1 Finch Therapeutics Company Details
11.4.2 Finch Therapeutics Business Overview
11.4.3 Finch Therapeutics Faecal Microbiota Transplant(FMT) Therapy Introduction
11.4.4 Finch Therapeutics Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025)
11.4.5 Finch Therapeutics Recent Development
11.5 Crestovo
11.5.1 Crestovo Company Details
11.5.2 Crestovo Business Overview
11.5.3 Crestovo Faecal Microbiota Transplant(FMT) Therapy Introduction
11.5.4 Crestovo Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025)
11.5.5 Crestovo Recent Development
11.6 Maat Pharma
11.6.1 Maat Pharma Company Details
11.6.2 Maat Pharma Business Overview
11.6.3 Maat Pharma Faecal Microbiota Transplant(FMT) Therapy Introduction
11.6.4 Maat Pharma Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025)
11.6.5 Maat Pharma Recent Development
11.7 Seres Therapeutics
11.7.1 Seres Therapeutics Company Details
11.7.2 Seres Therapeutics Business Overview
11.7.3 Seres Therapeutics Faecal Microbiota Transplant(FMT) Therapy Introduction
11.7.4 Seres Therapeutics Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025)
11.7.5 Seres Therapeutics Recent Development
11.8 Second Genome
11.8.1 Second Genome Company Details
11.8.2 Second Genome Business Overview
11.8.3 Second Genome Faecal Microbiota Transplant(FMT) Therapy Introduction
11.8.4 Second Genome Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025)
11.8.5 Second Genome Recent Development
11.9 OpenBiome
11.9.1 OpenBiome Company Details
11.9.2 OpenBiome Business Overview
11.9.3 OpenBiome Faecal Microbiota Transplant(FMT) Therapy Introduction
11.9.4 OpenBiome Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025)
11.9.5 OpenBiome Recent Development
11.10 MicroBiome Therapeutics
11.10.1 MicroBiome Therapeutics Company Details
11.10.2 MicroBiome Therapeutics Business Overview
11.10.3 MicroBiome Therapeutics Faecal Microbiota Transplant(FMT) Therapy Introduction
11.10.4 MicroBiome Therapeutics Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025)
11.10.5 MicroBiome Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Faecal Microbiota Transplant(FMT) Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Oral
Table 3. Key Players of Enema
Table 4. Global Faecal Microbiota Transplant(FMT) Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Faecal Microbiota Transplant(FMT) Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Faecal Microbiota Transplant(FMT) Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Faecal Microbiota Transplant(FMT) Therapy Market Share by Region (2020-2025)
Table 8. Global Faecal Microbiota Transplant(FMT) Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Faecal Microbiota Transplant(FMT) Therapy Market Share by Region (2026-2031)
Table 10. Faecal Microbiota Transplant(FMT) Therapy Market Trends
Table 11. Faecal Microbiota Transplant(FMT) Therapy Market Drivers
Table 12. Faecal Microbiota Transplant(FMT) Therapy Market Challenges
Table 13. Faecal Microbiota Transplant(FMT) Therapy Market Restraints
Table 14. Global Faecal Microbiota Transplant(FMT) Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Faecal Microbiota Transplant(FMT) Therapy Market Share by Players (2020-2025)
Table 16. Global Top Faecal Microbiota Transplant(FMT) Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Faecal Microbiota Transplant(FMT) Therapy as of 2024)
Table 17. Ranking of Global Top Faecal Microbiota Transplant(FMT) Therapy Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Faecal Microbiota Transplant(FMT) Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Faecal Microbiota Transplant(FMT) Therapy, Headquarters and Area Served
Table 20. Global Key Players of Faecal Microbiota Transplant(FMT) Therapy, Product and Application
Table 21. Global Key Players of Faecal Microbiota Transplant(FMT) Therapy, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Faecal Microbiota Transplant(FMT) Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share by Type (2020-2025)
Table 25. Global Faecal Microbiota Transplant(FMT) Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share by Type (2026-2031)
Table 27. Global Faecal Microbiota Transplant(FMT) Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share by Application (2020-2025)
Table 29. Global Faecal Microbiota Transplant(FMT) Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share by Application (2026-2031)
Table 31. North America Faecal Microbiota Transplant(FMT) Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Faecal Microbiota Transplant(FMT) Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Faecal Microbiota Transplant(FMT) Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 46. Enterome Bioscience Company Details
Table 47. Enterome Bioscience Business Overview
Table 48. Enterome Bioscience Faecal Microbiota Transplant(FMT) Therapy Product
Table 49. Enterome Bioscience Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025) & (US$ Million)
Table 50. Enterome Bioscience Recent Development
Table 51. Rebiotix Company Details
Table 52. Rebiotix Business Overview
Table 53. Rebiotix Faecal Microbiota Transplant(FMT) Therapy Product
Table 54. Rebiotix Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025) & (US$ Million)
Table 55. Rebiotix Recent Development
Table 56. Ritter Pharmaceuticals Company Details
Table 57. Ritter Pharmaceuticals Business Overview
Table 58. Ritter Pharmaceuticals Faecal Microbiota Transplant(FMT) Therapy Product
Table 59. Ritter Pharmaceuticals Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025) & (US$ Million)
Table 60. Ritter Pharmaceuticals Recent Development
Table 61. Finch Therapeutics Company Details
Table 62. Finch Therapeutics Business Overview
Table 63. Finch Therapeutics Faecal Microbiota Transplant(FMT) Therapy Product
Table 64. Finch Therapeutics Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025) & (US$ Million)
Table 65. Finch Therapeutics Recent Development
Table 66. Crestovo Company Details
Table 67. Crestovo Business Overview
Table 68. Crestovo Faecal Microbiota Transplant(FMT) Therapy Product
Table 69. Crestovo Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025) & (US$ Million)
Table 70. Crestovo Recent Development
Table 71. Maat Pharma Company Details
Table 72. Maat Pharma Business Overview
Table 73. Maat Pharma Faecal Microbiota Transplant(FMT) Therapy Product
Table 74. Maat Pharma Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025) & (US$ Million)
Table 75. Maat Pharma Recent Development
Table 76. Seres Therapeutics Company Details
Table 77. Seres Therapeutics Business Overview
Table 78. Seres Therapeutics Faecal Microbiota Transplant(FMT) Therapy Product
Table 79. Seres Therapeutics Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025) & (US$ Million)
Table 80. Seres Therapeutics Recent Development
Table 81. Second Genome Company Details
Table 82. Second Genome Business Overview
Table 83. Second Genome Faecal Microbiota Transplant(FMT) Therapy Product
Table 84. Second Genome Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025) & (US$ Million)
Table 85. Second Genome Recent Development
Table 86. OpenBiome Company Details
Table 87. OpenBiome Business Overview
Table 88. OpenBiome Faecal Microbiota Transplant(FMT) Therapy Product
Table 89. OpenBiome Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025) & (US$ Million)
Table 90. OpenBiome Recent Development
Table 91. MicroBiome Therapeutics Company Details
Table 92. MicroBiome Therapeutics Business Overview
Table 93. MicroBiome Therapeutics Faecal Microbiota Transplant(FMT) Therapy Product
Table 94. MicroBiome Therapeutics Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025) & (US$ Million)
Table 95. MicroBiome Therapeutics Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report
List of Figures
Figure 1. Faecal Microbiota Transplant(FMT) Therapy Picture
Figure 2. Global Faecal Microbiota Transplant(FMT) Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Faecal Microbiota Transplant(FMT) Therapy Market Share by Type: 2024 VS 2031
Figure 4. Oral Features
Figure 5. Enema Features
Figure 6. Global Faecal Microbiota Transplant(FMT) Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Faecal Microbiota Transplant(FMT) Therapy Market Share by Application: 2024 VS 2031
Figure 8. Clostridioides Difficile Infection(CDI) Case Studies
Figure 9. Digestive System Disease Case Studies
Figure 10. Nervous System Disease Case Studies
Figure 11. Others Case Studies
Figure 12. Faecal Microbiota Transplant(FMT) Therapy Report Years Considered
Figure 13. Global Faecal Microbiota Transplant(FMT) Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Faecal Microbiota Transplant(FMT) Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Faecal Microbiota Transplant(FMT) Therapy Market Share by Region: 2024 VS 2031
Figure 16. Global Faecal Microbiota Transplant(FMT) Therapy Market Share by Players in 2024
Figure 17. Global Top Faecal Microbiota Transplant(FMT) Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Faecal Microbiota Transplant(FMT) Therapy as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Faecal Microbiota Transplant(FMT) Therapy Revenue in 2024
Figure 19. North America Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Faecal Microbiota Transplant(FMT) Therapy Market Share by Country (2020-2031)
Figure 21. United States Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Faecal Microbiota Transplant(FMT) Therapy Market Share by Country (2020-2031)
Figure 25. Germany Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Market Share by Region (2020-2031)
Figure 33. China Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Faecal Microbiota Transplant(FMT) Therapy Market Share by Country (2020-2031)
Figure 41. Mexico Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Market Share by Country (2020-2031)
Figure 45. Turkey Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Enterome Bioscience Revenue Growth Rate in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025)
Figure 49. Rebiotix Revenue Growth Rate in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025)
Figure 50. Ritter Pharmaceuticals Revenue Growth Rate in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025)
Figure 51. Finch Therapeutics Revenue Growth Rate in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025)
Figure 52. Crestovo Revenue Growth Rate in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025)
Figure 53. Maat Pharma Revenue Growth Rate in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025)
Figure 54. Seres Therapeutics Revenue Growth Rate in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025)
Figure 55. Second Genome Revenue Growth Rate in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025)
Figure 56. OpenBiome Revenue Growth Rate in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025)
Figure 57. MicroBiome Therapeutics Revenue Growth Rate in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Table 1. Global Faecal Microbiota Transplant(FMT) Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Oral
Table 3. Key Players of Enema
Table 4. Global Faecal Microbiota Transplant(FMT) Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Faecal Microbiota Transplant(FMT) Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Faecal Microbiota Transplant(FMT) Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Faecal Microbiota Transplant(FMT) Therapy Market Share by Region (2020-2025)
Table 8. Global Faecal Microbiota Transplant(FMT) Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Faecal Microbiota Transplant(FMT) Therapy Market Share by Region (2026-2031)
Table 10. Faecal Microbiota Transplant(FMT) Therapy Market Trends
Table 11. Faecal Microbiota Transplant(FMT) Therapy Market Drivers
Table 12. Faecal Microbiota Transplant(FMT) Therapy Market Challenges
Table 13. Faecal Microbiota Transplant(FMT) Therapy Market Restraints
Table 14. Global Faecal Microbiota Transplant(FMT) Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Faecal Microbiota Transplant(FMT) Therapy Market Share by Players (2020-2025)
Table 16. Global Top Faecal Microbiota Transplant(FMT) Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Faecal Microbiota Transplant(FMT) Therapy as of 2024)
Table 17. Ranking of Global Top Faecal Microbiota Transplant(FMT) Therapy Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Faecal Microbiota Transplant(FMT) Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Faecal Microbiota Transplant(FMT) Therapy, Headquarters and Area Served
Table 20. Global Key Players of Faecal Microbiota Transplant(FMT) Therapy, Product and Application
Table 21. Global Key Players of Faecal Microbiota Transplant(FMT) Therapy, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Faecal Microbiota Transplant(FMT) Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share by Type (2020-2025)
Table 25. Global Faecal Microbiota Transplant(FMT) Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share by Type (2026-2031)
Table 27. Global Faecal Microbiota Transplant(FMT) Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share by Application (2020-2025)
Table 29. Global Faecal Microbiota Transplant(FMT) Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share by Application (2026-2031)
Table 31. North America Faecal Microbiota Transplant(FMT) Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Faecal Microbiota Transplant(FMT) Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Faecal Microbiota Transplant(FMT) Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 46. Enterome Bioscience Company Details
Table 47. Enterome Bioscience Business Overview
Table 48. Enterome Bioscience Faecal Microbiota Transplant(FMT) Therapy Product
Table 49. Enterome Bioscience Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025) & (US$ Million)
Table 50. Enterome Bioscience Recent Development
Table 51. Rebiotix Company Details
Table 52. Rebiotix Business Overview
Table 53. Rebiotix Faecal Microbiota Transplant(FMT) Therapy Product
Table 54. Rebiotix Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025) & (US$ Million)
Table 55. Rebiotix Recent Development
Table 56. Ritter Pharmaceuticals Company Details
Table 57. Ritter Pharmaceuticals Business Overview
Table 58. Ritter Pharmaceuticals Faecal Microbiota Transplant(FMT) Therapy Product
Table 59. Ritter Pharmaceuticals Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025) & (US$ Million)
Table 60. Ritter Pharmaceuticals Recent Development
Table 61. Finch Therapeutics Company Details
Table 62. Finch Therapeutics Business Overview
Table 63. Finch Therapeutics Faecal Microbiota Transplant(FMT) Therapy Product
Table 64. Finch Therapeutics Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025) & (US$ Million)
Table 65. Finch Therapeutics Recent Development
Table 66. Crestovo Company Details
Table 67. Crestovo Business Overview
Table 68. Crestovo Faecal Microbiota Transplant(FMT) Therapy Product
Table 69. Crestovo Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025) & (US$ Million)
Table 70. Crestovo Recent Development
Table 71. Maat Pharma Company Details
Table 72. Maat Pharma Business Overview
Table 73. Maat Pharma Faecal Microbiota Transplant(FMT) Therapy Product
Table 74. Maat Pharma Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025) & (US$ Million)
Table 75. Maat Pharma Recent Development
Table 76. Seres Therapeutics Company Details
Table 77. Seres Therapeutics Business Overview
Table 78. Seres Therapeutics Faecal Microbiota Transplant(FMT) Therapy Product
Table 79. Seres Therapeutics Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025) & (US$ Million)
Table 80. Seres Therapeutics Recent Development
Table 81. Second Genome Company Details
Table 82. Second Genome Business Overview
Table 83. Second Genome Faecal Microbiota Transplant(FMT) Therapy Product
Table 84. Second Genome Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025) & (US$ Million)
Table 85. Second Genome Recent Development
Table 86. OpenBiome Company Details
Table 87. OpenBiome Business Overview
Table 88. OpenBiome Faecal Microbiota Transplant(FMT) Therapy Product
Table 89. OpenBiome Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025) & (US$ Million)
Table 90. OpenBiome Recent Development
Table 91. MicroBiome Therapeutics Company Details
Table 92. MicroBiome Therapeutics Business Overview
Table 93. MicroBiome Therapeutics Faecal Microbiota Transplant(FMT) Therapy Product
Table 94. MicroBiome Therapeutics Revenue in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025) & (US$ Million)
Table 95. MicroBiome Therapeutics Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report
List of Figures
Figure 1. Faecal Microbiota Transplant(FMT) Therapy Picture
Figure 2. Global Faecal Microbiota Transplant(FMT) Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Faecal Microbiota Transplant(FMT) Therapy Market Share by Type: 2024 VS 2031
Figure 4. Oral Features
Figure 5. Enema Features
Figure 6. Global Faecal Microbiota Transplant(FMT) Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Faecal Microbiota Transplant(FMT) Therapy Market Share by Application: 2024 VS 2031
Figure 8. Clostridioides Difficile Infection(CDI) Case Studies
Figure 9. Digestive System Disease Case Studies
Figure 10. Nervous System Disease Case Studies
Figure 11. Others Case Studies
Figure 12. Faecal Microbiota Transplant(FMT) Therapy Report Years Considered
Figure 13. Global Faecal Microbiota Transplant(FMT) Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Faecal Microbiota Transplant(FMT) Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Faecal Microbiota Transplant(FMT) Therapy Market Share by Region: 2024 VS 2031
Figure 16. Global Faecal Microbiota Transplant(FMT) Therapy Market Share by Players in 2024
Figure 17. Global Top Faecal Microbiota Transplant(FMT) Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Faecal Microbiota Transplant(FMT) Therapy as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Faecal Microbiota Transplant(FMT) Therapy Revenue in 2024
Figure 19. North America Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Faecal Microbiota Transplant(FMT) Therapy Market Share by Country (2020-2031)
Figure 21. United States Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Faecal Microbiota Transplant(FMT) Therapy Market Share by Country (2020-2031)
Figure 25. Germany Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Faecal Microbiota Transplant(FMT) Therapy Market Share by Region (2020-2031)
Figure 33. China Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Faecal Microbiota Transplant(FMT) Therapy Market Share by Country (2020-2031)
Figure 41. Mexico Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Market Share by Country (2020-2031)
Figure 45. Turkey Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Faecal Microbiota Transplant(FMT) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Enterome Bioscience Revenue Growth Rate in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025)
Figure 49. Rebiotix Revenue Growth Rate in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025)
Figure 50. Ritter Pharmaceuticals Revenue Growth Rate in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025)
Figure 51. Finch Therapeutics Revenue Growth Rate in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025)
Figure 52. Crestovo Revenue Growth Rate in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025)
Figure 53. Maat Pharma Revenue Growth Rate in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025)
Figure 54. Seres Therapeutics Revenue Growth Rate in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025)
Figure 55. Second Genome Revenue Growth Rate in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025)
Figure 56. OpenBiome Revenue Growth Rate in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025)
Figure 57. MicroBiome Therapeutics Revenue Growth Rate in Faecal Microbiota Transplant(FMT) Therapy Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232